Analogic Corporation (ALOG) Stake Raised by Morgan Stanley

Morgan Stanley boosted its stake in Analogic Corporation (NASDAQ:ALOG) by 24.5% during the first quarter, Holdings Channel reports. The firm owned 46,331 shares of the medical research company’s stock after buying an additional 9,108 shares during the period. Morgan Stanley’s holdings in Analogic Corporation were worth $3,518,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp raised its position in Analogic Corporation by 104.9% in the first quarter. Bank of New York Mellon Corp now owns 368,958 shares of the medical research company’s stock valued at $28,004,000 after buying an additional 188,891 shares during the period. US Bancorp DE raised its position in Analogic Corporation by 59.0% in the first quarter. US Bancorp DE now owns 1,635 shares of the medical research company’s stock valued at $124,000 after buying an additional 607 shares during the period. First Trust Advisors LP raised its position in Analogic Corporation by 194.6% in the first quarter. First Trust Advisors LP now owns 10,162 shares of the medical research company’s stock valued at $771,000 after buying an additional 6,713 shares during the period. Stoneridge Investment Partners LLC raised its position in Analogic Corporation by 148.8% in the first quarter. Stoneridge Investment Partners LLC now owns 20,933 shares of the medical research company’s stock valued at $1,589,000 after buying an additional 12,521 shares during the period. Finally, Great West Life Assurance Co. Can raised its position in Analogic Corporation by 7.1% in the first quarter. Great West Life Assurance Co. Can now owns 17,446 shares of the medical research company’s stock valued at $1,324,000 after buying an additional 1,160 shares during the period.

Analogic Corporation (NASDAQ ALOG) traded down 0.87% on Friday, hitting $68.65. 11,093 shares of the company traded hands. The firm’s market capitalization is $856.07 million. Analogic Corporation has a 12 month low of $66.00 and a 12 month high of $95.85. The stock’s 50-day moving average is $70.89 and its 200 day moving average is $73.37.

Analogic Corporation (NASDAQ:ALOG) last issued its quarterly earnings data on Tuesday, June 6th. The medical research company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.05. The business had revenue of $122.16 million during the quarter, compared to the consensus estimate of $121.35 million. Analogic Corporation had a negative net margin of 7.97% and a positive return on equity of 6.75%. The company’s revenue was down 4.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.80 EPS. Equities analysts forecast that Analogic Corporation will post $2.60 EPS for the current fiscal year.

WARNING: “Analogic Corporation (ALOG) Stake Raised by Morgan Stanley” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://sportsperspectives.com/2017/08/18/analogic-corporation-alog-stake-raised-by-morgan-stanley.html.

Separately, Jefferies Group LLC assumed coverage on shares of Analogic Corporation in a research note on Wednesday, August 9th. They set a “hold” rating and a $75.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $87.00.

About Analogic Corporation

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Corporation (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic Corporation (NASDAQ:ALOG)

Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply